Market Tracker

10/31 7:05pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

23.26
Data as of Oct 31
 +0.53 / +2.33%
Today’s Change
9.71
Today|||52-Week Range
23.84
+130.75%
Year-to-Date

Today’s Trading

Previous close22.73
Today’s open23.28
Day’s range22.56 - 23.84
Volume574,209
Average volume (3 months)308,880
Market cap$738.2M
Dividend yield--
Data as of 10/31/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+25.71%
Earnings growth (next 5 years)+19.70%
Revenue growth (last year)+8.77%
P/E ratio--
Price/Sales1.26
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...+0.01+0.69%
SGMOSangamo BioSciences ...+0.23+1.93%
BRLIBio-Reference Labora...+0.11+0.37%
DBVTDBV Technologies SA+0.21+0.84%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)$0.16
Annual revenue (last year)$246.6M
Annual profit (last year)$12.7M
Net profit margin5.14%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
SVP
Michael Nolan
Corporate headquarters
Albany, New York

Forecasts